In addition, distinct CD4+ T cell subsets, such as Th1 and Th17 helper T cells, which contribute to MASLD to MASH progression (Her et al., 2020), might have a critical role in the MASH to HCC transition. This evidence concerns the gene CD4 and hepatocellular carcinoma.